Changjiang Pharmaceutical Group Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Changjiang Pharmaceutical Group.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Auto Components earnings growth | 25.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Shares Climb 53% But Its Business Is Yet to Catch Up
Nov 14
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Changjiang Pharmaceutical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 277 | -671 | -220 | -212 | N/A |
| 6/30/2024 | 795 | -734 | -197 | -190 | N/A |
| 3/31/2024 | 1,120 | -630 | -213 | -205 | N/A |
| 12/31/2023 | 1,198 | -606 | -154 | -147 | N/A |
| 9/30/2023 | 1,215 | -167 | 82 | 62 | N/A |
| 6/30/2023 | 1,099 | -7 | 57 | 35 | N/A |
| 3/31/2023 | 1,207 | -61 | 6 | 0 | N/A |
| 1/1/2023 | 1,615 | -23 | -118 | -66 | N/A |
| 9/30/2022 | 1,966 | -20 | -222 | -50 | N/A |
| 6/30/2022 | 2,056 | -75 | -101 | 103 | N/A |
| 3/31/2022 | 2,122 | 4 | 25 | 225 | N/A |
| 1/1/2022 | 2,362 | 49 | 89 | 231 | N/A |
| 9/30/2021 | 2,388 | 121 | 168 | 233 | N/A |
| 6/30/2021 | 2,143 | 117 | 73 | 106 | N/A |
| 3/31/2021 | 1,874 | 90 | -16 | 3 | N/A |
| 12/31/2020 | 1,215 | 25 | 14 | 33 | N/A |
| 9/30/2020 | 784 | -696 | -58 | -56 | N/A |
| 6/30/2020 | 636 | -723 | -35 | -34 | N/A |
| 3/31/2020 | 591 | -700 | 15 | 20 | N/A |
| 12/31/2019 | 725 | -670 | 17 | 22 | N/A |
| 9/30/2019 | 763 | 22 | 86 | 96 | N/A |
| 6/30/2019 | 897 | 81 | 97 | 108 | N/A |
| 3/31/2019 | 988 | 115 | 176 | 185 | N/A |
| 12/31/2018 | 881 | 102 | 128 | 137 | N/A |
| 9/30/2018 | 947 | 123 | 125 | 130 | N/A |
| 6/30/2018 | 898 | 103 | N/A | 76 | N/A |
| 3/31/2018 | 829 | 80 | N/A | -18 | N/A |
| 12/31/2017 | 744 | 70 | N/A | 39 | N/A |
| 9/30/2017 | 564 | 53 | N/A | 9 | N/A |
| 6/30/2017 | 409 | 35 | N/A | 25 | N/A |
| 3/31/2017 | 241 | 5 | N/A | -7 | N/A |
| 12/31/2016 | 235 | 4 | N/A | -18 | N/A |
| 9/30/2016 | 214 | 6 | N/A | 24 | N/A |
| 6/30/2016 | 194 | -1 | N/A | 20 | N/A |
| 3/31/2016 | 195 | 4 | N/A | 58 | N/A |
| 12/31/2015 | 191 | 5 | N/A | 41 | N/A |
| 9/30/2015 | 214 | 11 | N/A | -3 | N/A |
| 6/30/2015 | 231 | 21 | N/A | -51 | N/A |
| 3/31/2015 | 244 | 26 | N/A | -37 | N/A |
| 12/31/2014 | 243 | 29 | N/A | -39 | N/A |
| 9/30/2014 | 254 | 35 | N/A | 18 | N/A |
| 6/30/2014 | 248 | 34 | N/A | 23 | N/A |
| 3/31/2014 | 254 | 34 | N/A | -10 | N/A |
| 12/31/2013 | 255 | 35 | N/A | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 300391's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 300391's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 300391's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 300391's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300391's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300391's Return on Equity is forecast to be high in 3 years time